Rick Pollack, president of the American Hospital Association, and Marilyn Tavenner, CEO of America’s Health Insurance Plans, in a joint essay in The Hill press for improving federal marketplace offerings and lowering the cost of life-saving drugs.
Among other things, they urge physicians, nurses, health plans and other in the healthcare sector to join to push cost controls.
But they also discussed the successes in cost control that have been achieved in such areas as Medicare Advantage, Medicare Part D, Medicare Shared Savings Program and Medicaid managed-care plans.
“A healthy private market – with real choice, informed consumers, and effective care and treatments – can deliver better quality and affordable coverage for everyone,” they wrote.
They added: “Unjustified and unaccountable spikes in prescription drug prices are the engine of higher costs. Despite historic lows in overall cost growth for years, drug spending grew by more than 12 percent in 2014 – and is expected to outpace overall growth for the foreseeable future,” they wrote.
To read the piece from The Hill, please hit this link.